Saraschandra Vallabhajosyula1,2,3,4, Jacob C Jentzer1,2, Jeffrey B Geske1, Mukesh Kumar3,5, Ankit Sakhuja2, Akhil Singhal3,5, Joseph T Poterucha2, Kianoush Kashani2,3,6, Joseph G Murphy1, Ognjen Gajic2,3, Rahul Kashyap3,5. 1. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. 2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota. 3. Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Laboratory, Mayo Clinic, Rochester, Minnesota. 4. Center for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota. 5. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota. 6. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: The association between new-onset left ventricular (LV) dysfunction during sepsis with long-term heart failure outcomes is lesser understood. METHODS: Retrospective cohort study of all adult patients with severe sepsis and septic shock between 2007 and 2014 who underwent echocardiography within 72 h of admission to the intensive care unit. Patients with prior heart failure, LV dysfunction, and structural heart disease were excluded. LV systolic dysfunction was defined as LV ejection fraction <50% and LV diastolic dysfunction as ≥grade II. Primary composite outcome included new hospitalization for acute decompensated heart failure and all-cause mortality at 2-year follow-up. Secondary outcomes included persistent LV dysfunction, and hospital mortality and length of stay. RESULTS: During this 8-year period, 434 patients with 206 (48%) patients having LV dysfunction were included. The two groups had similar baseline characteristics, but those with LV dysfunction had worse function as demonstrated by worse LV ejection fraction, cardiac index, and LV diastolic dysfunction. In the 331 hospital survivors, new-onset acute decompensated heart failure hospitalization did not differ between the two cohorts (15% vs. 11%). The primary composite outcome was comparable at 2-year follow-up between the groups with and without LV dysfunction (P = 0.24). Persistent LV dysfunction was noted in 28% hospital survivors on follow-up echocardiography. Other secondary outcomes were similar between the two groups. CONCLUSIONS: In patients with severe sepsis and septic shock, the presence of new-onset LV dysfunction did not increase the risk of long-term adverse heart failure outcomes.
BACKGROUND: The association between new-onset left ventricular (LV) dysfunction during sepsis with long-term heart failure outcomes is lesser understood. METHODS: Retrospective cohort study of all adult patients with severe sepsis and septic shock between 2007 and 2014 who underwent echocardiography within 72 h of admission to the intensive care unit. Patients with prior heart failure, LV dysfunction, and structural heart disease were excluded. LV systolic dysfunction was defined as LV ejection fraction <50% and LV diastolic dysfunction as ≥grade II. Primary composite outcome included new hospitalization for acute decompensated heart failure and all-cause mortality at 2-year follow-up. Secondary outcomes included persistent LV dysfunction, and hospital mortality and length of stay. RESULTS: During this 8-year period, 434 patients with 206 (48%) patients having LV dysfunction were included. The two groups had similar baseline characteristics, but those with LV dysfunction had worse function as demonstrated by worse LV ejection fraction, cardiac index, and LV diastolic dysfunction. In the 331 hospital survivors, new-onset acute decompensated heart failure hospitalization did not differ between the two cohorts (15% vs. 11%). The primary composite outcome was comparable at 2-year follow-up between the groups with and without LV dysfunction (P = 0.24). Persistent LV dysfunction was noted in 28% hospital survivors on follow-up echocardiography. Other secondary outcomes were similar between the two groups. CONCLUSIONS: In patients with severe sepsis and septic shock, the presence of new-onset LV dysfunction did not increase the risk of long-term adverse heart failure outcomes.
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista Journal: J Am Soc Echocardiogr Date: 2009-02 Impact factor: 5.251
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Filippo Sanfilippo; Carlos Corredor; Nick Fletcher; Giora Landesberg; Umberto Benedetto; Pierre Foex; Maurizio Cecconi Journal: Intensive Care Med Date: 2015-03-24 Impact factor: 17.440
Authors: Giora Landesberg; Allan S Jaffe; Dan Gilon; Phillip D Levin; Sergey Goodman; Abed Abu-Baih; Ronen Beeri; Charles Weissman; Charles L Sprung; Amir Landesberg Journal: Crit Care Med Date: 2014-04 Impact factor: 7.598
Authors: Balwinder Singh; Amandeep Singh; Adil Ahmed; Gregory A Wilson; Brian W Pickering; Vitaly Herasevich; Ognjen Gajic; Guangxi Li Journal: Mayo Clin Proc Date: 2012-09 Impact factor: 7.616
Authors: Michael J Lanspa; Andrea R Gutsche; Emily L Wilson; Troy D Olsen; Eliotte L Hirshberg; Daniel B Knox; Samuel M Brown; Colin K Grissom Journal: Crit Care Date: 2016-08-04 Impact factor: 9.097
Authors: Sangeeta Mehta; John Granton; Anthony C Gordon; Deborah J Cook; Stephen Lapinsky; Gary Newton; Kris Bandayrel; Anjuli Little; Chuin Siau; Dieter Ayers; Joel Singer; Terry C K Lee; Keith R Walley; Michelle Storms; D James Cooper; Cheryl L Holmes; Paul Hebert; Jeffrey Presneill; James A Russell Journal: Crit Care Date: 2013-06-20 Impact factor: 9.097
Authors: Leah B Kosyakovsky; Federico Angriman; Emma Katz; Neill K Adhikari; Lucas C Godoy; John C Marshall; Bruno L Ferreyro; Douglas S Lee; Robert S Rosenson; Naveed Sattar; Subodh Verma; Augustin Toma; Marina Englesakis; Barry Burstein; Michael E Farkouh; Margaret Herridge; Dennis T Ko; Damon C Scales; Michael E Detsky; Lior Bibas; Patrick R Lawler Journal: Intensive Care Med Date: 2021-08-09 Impact factor: 17.440
Authors: Kristen T Crowell; Samantha Moreno; Jennifer L Steiner; Catherine S Coleman; David I Soybel; Charles H Lang Journal: Shock Date: 2018-12 Impact factor: 3.454
Authors: Sarah J Beesley; Jeff Sorensen; Allan J Walkey; Joseph E Tonna; Michael J Lanspa; Ellie Hirshberg; Colin K Grissom; Benjamin D Horne; Rebecca Burk; Theodore P Abraham; Robert Paine; Samuel M Brown Journal: Crit Care Med Date: 2021-04-01 Impact factor: 9.296